openPR Logo
Press release

Endothelial Dysfunction Market Growing at a Healthy Rate

01-25-2018 01:23 PM CET | Health & Medicine

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Endothelial Dysfunction Market Growing at a Healthy Rate

Global Endothelial Dysfunction Market: Synopsis

Endothelium is an inert lining of the blood vessels which act as highly specialized and metabolically active interface between the blood and the underlying tissues. The basic activities of endothelium encompass mediation of coagulation, platelet adhesion, immune function and control of volume and electrolyte content of the intravascular and extravascular spaces. Endothelium dysfunction can be defined as partial or complete loss of balance between vasodilating and vasoconstricting substances produced by the endothelium.

Endothelium dysfunction can contribute to several disorders such as hypertension, diabetes, hypercholesterolaemia, Behcet's disease among others. Endothelium dysfunction is now regarded as an early pivotal event in atherogenesis and has been considered an important event in the development of micro vascular complications in diabetes. Nitric oxide reduction is regarded as one of the prominent features of the endothelial dysfunction. Nitric oxide has following physiological effect which contributes to the inhibition of atherosclerosis which include reduction in LDL oxidation, decrease in platelet aggregation to the endothelium, inhibition of smooth muscles cell proliferation and prevention of leukocyte adhesion and infiltration into the vessel.

Request Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=17273

Global Endothelial Dysfunction Market: Trends and Prospects

The testing and diagnosis method for endothelial dysfunction include angiography with acetylcholine injection, however due to complex and invasive nature of diagnosis till date it has never been used beyond research activities. The non-invasive method to measure endothelial dysfunction comprises percent flow mediated dilation method measured by Brachial Artery Ultrasound Imaging devices. Though the technique is simple yet the acceptance across globe is hampered due to variation in results. A negative correlation between percent flow mediated dilation and baseline artery size is recognized as a fundamental scaling problem, leading to biased estimates of endothelial function. In 2003, FDA approved device EndoPAT which works by measuring Reactive Hyperemia Index (RHI) during nits clinical trials has shown significant results and up to 80% sensitivity as compared to acetylcoline angiogram.  Endothelial function can be improved significantly by exercise, smoke cessation, weight loss in overweight or obese persons, and improved diet. In past few years there has been a significant inclination by leading towards development of variety of novel drugs for treating endothelial dysfunction.

Some of the pipelined and available drugs in the market include maxacalcitol, S-adenosyl methionine, MC-1575 and paricalcitol among others. Some of the prominent drivers to the market include exponential rise in number of obese population, reduced physical activities and diabetes leading to increase in chances of acquiring cardiovascular diseases. Such factors have effectively contributed towards the growth and acceptance of variety of drugs and other therapeutics in past will continue to drive the market in forthcoming years as well. Advances in recombinant and gene therapy are also favoring the growth of endothelial dysfunction drugs uptake and can be an opportunity area for new entrants in the market.

 

Report Details @ https://www.transparencymarketresearch.com/endothelial-dysfunction-market.html

Global Endothelial Dysfunction Market: Regional Outlook

Geographically North America and Europe market is currently the leading market for the endothelial dysfunction products due to high involvement of research and development, advanced medical facilities and broad awareness related to cardiovascular diseases and other related diseases. Lack of government interventions and funds to conduct research and development have affected the growth and revenue share for emerging and developing nations. With the substantial rise in cardiovascular and diabetic case in the Asia-Pacific and Middle East countries in upcoming years the demand for endothelial dysfunction market is likely to grow in these regions in next 5-7 years.

Global Endothelial Dysfunction Market: Key Players

Some of the key players in the market include Abbott Laboratories, Chugai Pharmaceutical Co., Ltd., Johnson & Johnson, Glucox Biotech AB, Stealth Peptides Inc. among other prominent players in the market.

Request Pre Book @ https://www.transparencymarketresearch.com/checkout.php?rep_id=17273<ype=S

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endothelial Dysfunction Market Growing at a Healthy Rate here

News-ID: 917793 • Views:

More Releases from Transparency Market Research

Quartz Crystal Market: Projected to Grow at a 6.8% CAGR, Reaching USD 8.83 Billi …
The Global Quartz Crystal Market is set for significant growth, with market valuation projected to soar from USD 4.69 billion in 2021 to USD 8.83 billion by 2031, expanding at a robust compound annual growth rate (CAGR) of 6.8% from 2022 to 2031. This growth is primarily fueled by increasing demand in high-growth sectors such as consumer electronics and IT & telecommunications. Industry analysts highlight that companies in the quartz crystal
Global Silicon Photomultiplier Market to Reach USD 274.4 Million by 2031, Growin …
The Global Silicon Photomultiplier Market, valued at USD 123.7 million in 2021, is projected to reach USD 274.4 million by 2031, expanding at a compound annual growth rate (CAGR) of 8.3% from 2022 to 2031. This growth is driven by increasing demand across high-growth applications such as LiDAR, medical imaging, and analytical instrumentation. Silicon photomultipliers (SiPMs), known for their low voltage operation, excellent timing performance, high sensitivity, and immunity to
Global Thermoelectric Module Market Expected to Surpass US$ 1.2 Bn by 2031: Tran …
The Global Thermoelectric Module Market, valued at over US$ 0.5 Bn in 2021, is poised for substantial growth with an anticipated CAGR of 7.9% from 2022 to 2031. The market is projected to cross a value of US$ 1.2 Bn by the end of 2031, according to the latest industry analysis. Download Sample PDF from Here- https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=5444&utm_source=Openpr&utm_medium=Amit Market Drivers and Trends The demand for precise temperature control in various applications is significantly boosting
Global DCB and AMB Substrate Market Projected to Reach US$ 1.6 Billion by 2031: …
The Global DCB and AMB Substrate Market, valued at US$ 485.3 million in 2022, is set to advance at a CAGR of 14.1% from 2023 to 2031, reaching a projected value of US$ 1.6 billion by the end of 2031. These substrates, known for their excellent thermal insulation, are increasingly utilized in high-power and high-temperature applications across industries such as automotive, aerospace, and electronics. This growing demand is anticipated to

All 5 Releases


More Releases for Endothelial

08-12-2021 | Health & Medicine
Fact.MR
Endothelial Cells Latest Trends and Forecast Analysis up to 2031
250 Pages Endothelial Cells Market Survey by Fact MR, A Leading Business and Competitive Intelligence Provider Subtitle –Fact MR analysis of Endothelial Cells market provides compelling insights into the factors propelling sales prospects in key segments. It provides an executive-level blueprint of key market players' strategies and analyses their impact on overall growth projections. According to Fact MR’s recent market research, Endothelial Cells sales to swell at propelled CAGR through 2031, as
Global Endothelial Dysfunction Sales Market Strategies and Competitive Analysis …
Qyresearchreports include new market research report "Global Endothelial Dysfunction Sales Market Report 2017" to its huge collection of research reports. A thorough overview of the global market for Endothelial Dysfunction has been furnished in this research report. It offers a detailed analysis of the prominent trends prevailing in the market, including important growth drivers and restraints. The report, at the outset, provides a detailed overview of the products and outlines their
Endothelial Dysfunction Market - Worldwide Industry Analysis in 2024
Global Endothelial Dysfunction Market: Synopsis Endothelium is an inert lining of the blood vessels which act as highly specialized and metabolically active interface between the blood and the underlying tissues. The basic activities of endothelium encompass mediation of coagulation, platelet adhesion, immune function and control of volume and electrolyte content of the intravascular and extravascular spaces. Endothelium dysfunction can be defined as partial or complete loss of balance between vasodilating and
Endothelial Dysfunction Market shares and strategies of key players
Global Endothelial Dysfunction Market: Synopsis Endothelium is an inert lining of the blood vessels which act as highly specialized and metabolically active interface between the blood and the underlying tissues. The basic activities of endothelium encompass mediation of coagulation, platelet adhesion, immune function and control of volume and electrolyte content of the intravascular and extravascular spaces. Endothelium dysfunction can be defined as partial or complete loss of balance between vasodilating and
Endothelial Dysfunction Market Outlook And Research Survey To 2024
Global Endothelial Dysfunction Market: Synopsis Endothelium is an inert lining of the blood vessels which act as highly specialized and metabolically active interface between the blood and the underlying tissues. The basic activities of endothelium encompass mediation of coagulation, platelet adhesion, immune function and control of volume and electrolyte content of the intravascular and extravascular spaces. Endothelium dysfunction can be defined as partial or complete loss of balance between vasodilating and
Endothelial Dysfunction Market Report Forecasts High Growth by 2024
Global Endothelial Dysfunction Market: Synopsis Endothelium is an inert lining of the blood vessels which act as highly specialized and metabolically active interface between the blood and the underlying tissues. The basic activities of endothelium encompass mediation of coagulation, platelet adhesion, immune function and control of volume and electrolyte content of the intravascular and extravascular spaces. Endothelium dysfunction can be defined as partial or complete loss of balance between vasodilating and